The components of the protein C pathway play a critical role in preventing thrombosis, and, in vivo, activated protein c (APC) appears to exhibit anti-inflammatory activity. We have recently identified, cloned and initiated studies on the regulation of a novel endothelial cell protein C receptor (EPCR) that binds protein C or APC, but not several other related vitamin K dependent proteins. The structure of the protein reveals similarity to the CD1/MHC class 1 superfamily of proteins and to CCD41, a murine centrosome, cell cycle dependent protein. This proposal is designed to elucidate the functions of EPCR. The goals are to I) express and isolate EPCR; 2) establish structure-function relationships between EPCR and APC; 3) determine if EPCR binding to APC changes substrate specificity (as thrombomodulin does with thrombin), and augments factor Va inactivation, a hypothesis supported by the properties, cell specificity and sensitivity of EPCR to cytokines; 4) study the fate of APC-EPCR complexes on endothelium and heterologous cells; 5) determine if the EPCR-APC complex has anti-inflammatory activity; 6) determine if EPCR exists as a heterodimer on cell surfaces; 7) study the regulatory elements of the gene to establish the mechanisms of down regulation of EPCR in culture and in vivo; and 8) evaluate possible EPCR functions by antisense and antibody inhibition approaches in vivo and in cell culture. These studies will provide information on the structure, function and physiological role of EPCR, the most recently identified member of the protein C anticoagulant pathway.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL054804-03
Application #
6242513
Study Section
Project Start
1997-08-15
Project End
1998-07-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
van Sluis, G L; Bruggemann, L W; Esmon, C T et al. (2011) Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation. Cancer Lett 306:106-10
Srivastava, Arvind; Wang, Jianfang; Majumder, Rinku et al. (2002) Localization of phosphatidylserine binding sites to structural domains of factor Xa. J Biol Chem 277:1855-63
Alberio, L; Lammle, B; Esmon, C T (2001) Protein C replacement in severe meningococcemia: rationale and clinical experience. Clin Infect Dis 32:1338-46
Liaw, P C; Mather, T; Oganesyan, N et al. (2001) Identification of the protein C/activated protein C binding sites on the endothelial cell protein C receptor. Implications for a novel mode of ligand recognition by a major histocompatibility complex class 1-type receptor. J Biol Chem 276:8364-70
Faust, S N; Levin, M; Harrison, O B et al. (2001) Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 345:408-16
Taylor Jr, F B; Stearns-Kurosawa, D J; Kurosawa, S et al. (2000) The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 95:1680-6
Liaw, P C; Neuenschwander, P F; Smirnov, M D et al. (2000) Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. J Biol Chem 275:5447-52
Epperson, T K; Patel, K D; McEver, R P et al. (2000) Noncovalent association of P-selectin glycoprotein ligand-1 and minimal determinants for binding to P-selectin. J Biol Chem 275:7839-53
Gu, J M; Fukudome, K; Esmon, C T (2000) Characterization and regulation of the 5'-flanking region of the murine endothelial protein C receptor gene. J Biol Chem 275:12481-8
Kurosawa, S; Esmon, C T; Stearns-Kurosawa, D J (2000) The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b/CD18. J Immunol 165:4697-703

Showing the most recent 10 out of 47 publications